title: Low molecular weight lanthanide contrast agents: in vitro studies of mechanisms of action.
abstract: The MR contrast properties of a series of structurally dissimilar low molecular weight (LMW) gadolinium (Gd) and dysprosium (Dy) chelates have been investigated under controlled experimental conditions in various in vitro test systems. Relaxation analysis (water, pH = 5.8, 37 degrees C, .47 T) demonstrated the high dipolar relaxation efficacy of the tested Gd chelates. The T1 and T2 relaxivities of both metal chelate series decreased with decreasing hydration number, confirming the strong correlation between metal chelate structure and dipolar relaxivity. Susceptibility-induced T2 relaxation, commonly known as the susceptibility effect, is modulated primarily by the magnetic susceptibility and compartmentalization of the contrast agent. The influence of these parameters on the susceptibility effect of Dy diethylenetriamine penta-acetic acid bis-methylamide (DTPA-BMA) and GdDTPA-BMA was investigated in two-compartment in vitro models. In red blood cell suspensions (45% hematocrit, 37 degrees C, .47 T, 2 and 3 mM metal ion concentration), the T2 relaxation efficacy of DyDTPA-BMA was markedly improved due to susceptibility effects that were shown to depend on compartmentalization. As the relaxation ability of GdDTPA-BMA was modulated by the dipolar interactions, compartmentalization was not a prerequisite for its T2 relaxation efficacy. In a coaxial glass system with no intercompartmental water exchange, which eliminated the dipolar relaxation mechanism, DyDTPA-BMA was shown to be the most efficient susceptibility agent because of its higher magnetic susceptibility. The reported one- and two-compartment model studies have demonstrated the different mechanism of action of LMW Gd- and Dy-based contrast agents. Gd chelates are predominantly dipolar relaxation enhancers, whereas Dy chelates are efficient susceptibility agents only in compartmentalized systems.
authors.affiliation: Department of Medicinal Chemistry, School of Pharmacy, University of Oslo, Norway.
authors.forename: S
authors.initials: S
authors.lastname: Fossheim
authors.forename: K B
authors.initials: KB
authors.lastname: Saebø
authors.forename: A K
authors.initials: AK
authors.lastname: Fahlvik
authors.forename: P
authors.initials: P
authors.lastname: Rongved
authors.forename: J
authors.initials: J
authors.lastname: Klaveness
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D004058:Diffusion; D004419:Dysprosium / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D005682:Gadolinium / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D066298:In Vitro Techniques; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008954:Models, Biological; D008970:Molecular Weight; D011817:Rabbits; D012016:Reference Values
chemical_list: D003287:Contrast Media; D004419:Dysprosium; D005682:Gadolinium